Back
Open Access

Inositol 1,4,5-trisphosphate receptors (ITP3Rs) ablation reduces the expression of chemokine ligands and pro-inflammatory interleukins

Session: Advances in mechanisms of heart failure
Topic: Pathophysiology
Speaker: Doctor U. Kansakar (Bronx, US)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Urna Kansakar

Albert Einstein College of Medicine, Bronx (United States of America)
0 follower

6 more presentations in this session

Serum amyloid a1 reflects activation of interleukin 1b, 6, and 17 and is specifically upregulated in heart failure with a preserved ejection fraction

Speaker: Mr B. Van Essen (Groningen, NL)

Access
Abstract
Like
Thumbnail

Exhaled breath acetone as a biomarker of disease severity and exercise intolerance in heart failure

Speaker: Doctor N. De Biase (Pisa, IT)

Access
Abstract
Like
Thumbnail

Immune cell signature in non-ischemic heart failure indicates chronic activation and immunosenescence

Speaker: Mr L. Baumhove (Groningen, NL)

Access
Abstract
Like
Thumbnail

EDEM2 is a new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2

Speaker: Miss J. Zhang (Manchester, GB)

Access
Abstract
Like
Thumbnail

The role of EDEM2 in the heart under metabolic stress

Speaker: Miss O. Fonseka (Manchester, GB)

Access
Abstract
Like
Thumbnail

Access the full session

Advances in mechanisms of heart failure

Speakers: Doctor U. Kansakar, Mr B. Van Essen, Doctor N. De Biase, Mr L. Baumhove, Miss J. Zhang...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources